Lupin Manufacturing Solutions (LMS), a global contract research, development, and manufacturing organisation and a wholly
Lupin Limited has received approval from the European Commission for its biosimilar ranibizumab, marketed as
Lupin Limited announced the launch of Topiramate Extended-Release Capsules in the United States after receiving
Lupin Limited announced a strategic collaboration with TB Alliance, a nonprofit drug development organisation, to
Lupin Limited has entered into a licensing and supply agreement with Galenicum Health, S.L.U. for
Lupin Limited has signed an exclusive license, supply, and distribution agreement with Gan&Lee Pharmaceuticals of
Lupin Ltd has announced that its subsidiary, Lupin Manufacturing Solutions (LMS), has entered into a
Lupin Limited has announced that its greenhouse gas emission reduction targets have been formally validated
Lupin Manufacturing Solutions has entered into a strategic partnership with PolyPeptide Group to support the
Lupin Manufacturing Solutions (LMS), a wholly owned subsidiary of Lupin Limited, has inaugurated a specialized
